Styrenylcyclopropylamine LSD1 inhibitor 5 covalently inhibits LSD1 and shows the potent anticancer effects in a Kasumi-1 xenograft model of acute myeloid leukaemia.12 This evidence concerns the gene KDM1A and acute myeloid leukemia.